Why employers think 340B needs reform

Employers are advocating for changes to the 340B Drug Pricing Program, arguing that it allows hospitals to "buy low and sell high" by purchasing discounted medications and charging insured patients full price.

Editor's Pick

Top Story Why Employers Think the 340B Program Needs Reform Employers are advocating for changes to the 340B Drug Pricing Program, arguing that it allows hospitals to "buy low and sell high" by purchasing discounted medications and charging insured patients full price. Sponsored Driving Value at the Intersection of Payers, Providers, and Life Sciences Presented by Veradigm Transform claims into actionable insights with Veradigm. Our connected data solutions empower proactive care, helping providers and payers stay ahead of patient needs. Deliver smarter, faster, and more informed care decisions—starting now.  Unlock connected insights - Click to Learn More. Calling All Startups Utilizing AI Are you redefining healthcare operations with AI? We're looking for the next wave of digital health startups using artificial intelligence to transform the day-to-day work of providers. If your solution streamlines diagnosis, clinical documentation, scheduling, or patient engagement, this is your moment to shine. Click here to learn more and apply.

Featured News

Why Hospitals Must Rethink Operations Before Banking on AI Some hospitals are turning to AI to help manage declining revenue and financial pressure, but one expert says success depends on more than just buying new tech. Prashant Karamchandani of Chartis urges health systems to pair AI adoption with foundational work like change management, continuous improvement and operating model redesign. BioCryst Pharma Sells European Business for Rare Disease Drug in $250M Deal Neopharmed Gentili is acquiring European rights to Orladeyo, bringing the Italy-based pharmaceutical company into rare disease. BioCryst's Orladeyo is approved for treating patients with the rare disease hereditary angioedema. No Wrong Door: How Policy, Technology & Partnerships Can Power a Connected Social Safety Net Through the convergence of proactive policy, advanced technology and strategic public-private partnerships, we can achieve this "no wrong door" vision and deliver a connected, streamlined social safety net that's more efficient, economical, and effective. Here's how. The Administration's Autism Plan Is Controversial – But It Also Presents a Vital Opportunity Public debate is growing, but the real path forward lies in defining autism's biology — and for the first time, we can. The $232 Billion Problem: The Price of Overlooking the Impact of Trauma in the U.S. When we talk about post-traumatic stress disorder (PTSD), a condition fundamentally born from overwhelming experiences that leave a long-term imprint on the body, our mainstream approach often feels stuck in the past.

Video   Don't Stigmatize Obesity as Sign of Vanity At MedCity INVEST, Dr. Disha Narang, director of obesity medicine at Endeavor Health, discussed the stigma surrounding obesity. "Most patients that come to see me have tried everything under the sun to get weight off," she said. "They're not there to try to get into a fancy dress that's 10 or 15 pounds away from their goal. It's not necessarily something of vanity that we talk about. We talk about metabolic disease. When I'm seeing patients, they're having issues with heart disease, liver disease, diabetes."

Sponsored Navina's AI Copilot Eases the Value-Based Burden, Study Shows Presented by Navina A new independent study from Phyx Primary Care's Innovation Lab points to measurable improvements in physician burnout, documentation efficiency, and key VBC metrics among primary care practices. Learn More

Resources

MedCity Pivot Podcast: Mayo Clinic Florida Redefines Cancer Care In this latest episode, Arundhati explores how one Mayo Clinic doctor found purpose in her deeply personal tragedy and how Mayo Clinic Florida then took her idea, executed on it and is attempting to scale it. Watch now!

MedCity News • PO Box 901 • New York, NY unsubscribe